|
Dataset ID |
Tissue / Organ |
Experiment type |
Sample |
Cell type |
Marker class |
Evidence |
|
PRJNA610520 (3.5dpf) |
caudal hematopoietic tissue |
baseline |
3.5dpf, the mixture of same amount of kdrl:mCherry+ cells, CD41:GFP+ cells and double negative cells. |
Muscle cells (cluster: 17)
|
potential marker
|
NA
|
|
PRJNA564810 (5dpf) |
embryo |
baseline |
5dpf, a single-cell transcriptome atlas for zebrafish development |
Skeletal muscle cells (cluster: 12)
|
potential marker
|
NA
|
|
PRJNA564810 (2dpf) |
embryo |
baseline |
2dpf, a single-cell transcriptome atlas for zebrafish development |
Skeletal muscle cells (cluster: 17)
|
potential marker
|
NA
|
|
GSE158142 (3dpf) |
head |
baseline |
3dpf, untreatment |
Muscle cells (cluster: 16)
|
potential marker
|
NA
|
|
PRJNA554650 (6.5dpf) |
brain |
baseline |
6.5dpf, whole brain of nr1d1:VNP fish |
|
|
|
|
GSE158142 (5dpf) |
brain, eye |
baseline |
5dpf, untreatment |
|
|
|
|
GSE158142 (8dpf) |
brain, eye |
baseline |
8dpf, untreatment |
|
|
|
|
GSE158142 (15dpf) |
brain, eye |
baseline |
15dpf, untreatment |
|
|
|
|
PRJNA610520 (4.5dpf) |
caudal hematopoietic tissue |
baseline |
4.5dpf, the mixture of same amount of kdrl:mCherry+ cells, CD41:GFP+ cells and double negative cells. |
|
|
|
|
GSE144944 (fgfr3 +|+) |
cranial vault |
baseline |
1mpf, fgfr3 +/+ |
|
|
|
|
GSE144944 (fgfr3 -|-) |
cranial vault |
growth |
1mpf, fgfr3 -/- |
|
|
|
|
GSE106587 (WT) |
embryo |
baseline |
12hpf, 6 somites, wild-type TLAB embryo |
|
|
|
|
GSE168695 (5dpf) |
embryo |
baseline |
5dpf, GFP+ cells isolated from 5 dpf cldnb:lyn-EGFP embryos |
|
|
|
|
PRJNA734348 (dome, control) |
embryo |
baseline |
4.3hpf, dome, oocyte microinjection with Rhodamine B and control MO at oogenesis III stage (GV) |
|
|
|
|
GSE126647 (Pbx4-depleted) |
embryo |
growth |
1.17dpf, Pbx4-depleted nkx2.5:ZsYellow+ cells |
|
|
|
|
PRJNA564810 (1dpf) |
embryo |
baseline |
1dpf, a single-cell transcriptome atlas for zebrafish development |
|
|
|
|
PRJNA640816 (2.9dpf) |
embryo |
baseline |
2.9dpf, FACS isolated -4.9sox10:EGFP+ cells |
|
|
|
|
PRJNA656271 (1.5dpf) |
embryo |
baseline |
1.5dpf, FACS-isolated EGFP+ cells |
|
|
|
|
GSE158142 (24hpf) |
head |
baseline |
24hpf, untreatment |
|
|
|
|
GSE158142 (1.5dpf) |
head |
baseline |
1.5dpf, untreatment |
|
|
|
|
GSE158142 (20hpf) |
head |
baseline |
20hpf, 21-22 somites, untreatment |
|
|
|
|
GSE150498 (nod2-|-, 2X DSS+BZA) |
intestine |
disease |
6dpf, nod2-/-, 2X DSS+BZA |
|
|
|
|
GSE150498 (wildtype, 2X DSS) |
intestine |
disease |
6dpf, wildtype, 2X DSS |
|
|
|
|
GSE150498 (nod2-|-, untreated) |
intestine |
disease |
6dpf, nod2-/-, untreated |
|
|
|
|
GSE150498 (wildtype, 2X DSS+BZA) |
intestine |
disease |
6dpf, wildtype, 2X DSS+BZA |
|
|
|
|
GSE150498 (wildtype, 1X DSS) |
intestine |
disease |
6dpf, wildtype, 1X DSS |
|
|
|
|
GSE150498 (nod2-|-, 2X DSS) |
intestine |
disease |
6dpf, nod2-/-, 2X DSS |
|
|
|
|
GSE150498 (nod2-|-, 1X DSS) |
intestine |
disease |
6dpf, nod2-/-, 1X DSS |
|
|
|
|
GSE150498 (DSS treated) |
intestine |
disease |
6dpf, DSS treated |
|
|
|
|
PRJNA605021 (supporting cells) |
neuromast |
baseline |
7dpf, posterior lateral-line neuromast cells were isolated from the dissociated trunks of Tg[Et(krt4:EGFP)sqgw57A] transgenic zebrafish larvae |
|
|
|
|
PRJNA605021 (hair cells) |
neuromast |
baseline |
7dpf, posterior lateral-line neuromast cells were isolated from the dissociated trunks of Tg[myo6b:actb1-EGFP] transgenic zebrafish larvae |
|
|
|
|
GSE175929 (5mpf) |
retina |
baseline |
5mpf, GFP-positive cells collected from two transgenic zebrafish, Tg(rho:EGFP)ja2Tg and Tg(gnat2:EGFP)ja23Tg |
|
|
|
|
PRJNA551501 (2mpf) |
thyroid gland |
baseline |
2mpf, Tg(tg:mVenus-T2A-NTR) |
|
|
|
|
PRJNA551501 (8mpf) |
thyroid gland |
baseline |
8mpf, Tg(tg:mVenus-T2A-NTR) |
|
|
|
|
GSE152982 (wild type) |
trunk |
baseline |
1.25dpf, untreatment |
|
|
|
|
GSE131136 (all) |
trunk, skin |
baseline |
5dpf, sox10:CRE positive cells from 5dpf and post-embryonic zebrafish trunks with and without thyroid hormone |
|
|
|
|
PRJNA641144 (P_PRO) |
tumor |
disease |
adult, ZMEL1-PRO cells in vivo primary tumors |
|
|
|
|
PRJNA641144 (M_PRO) |
tumor |
disease |
adult, ZMEL1-PRO cells in vivo metastases |
|
|
|
|
GSE159709 (melanoma) |
tumor |
disease |
adult, equal numbers of sorted GFP+ (tumor) and GFP- (macroenvironment) cells |
|
|
|
|
PRJNA641144 (P_INV) |
tumor |
disease |
adult, ZMEL1-INV cells in vivo primary tumors |
|
|
|
|
GSE158099 (runx1 -|-) |
whole body |
hematopoietic |
16dpf, cd41:GFPlow-runx1-/- |
|
|
|
|
GSE158099 (WT) |
whole body |
baseline |
10dpf, cd41:GFPlow-WT |
|
|
|
|
GSE158099 (runx1 -|-) |
whole body |
hematopoietic |
2.5dpf, cd41:GFPlow-runx1-/- |
|
|
|
|
GSE158099 (runx1 -|-) |
whole body |
hematopoietic |
16dpf, cd41:GFPlow-runx1-/- |
|
|
|
|
GSE158099 (WT) |
whole body |
baseline |
6dpf, cd41:GFPlow-WT |
|
|
|
|
GSE158099 (runx1 -|-) |
whole body |
hematopoietic |
10dpf, cd41:GFPlow-runx1-/- |
|
|
|
|
GSE158099 (WT) |
whole body |
baseline |
16dpf, cd41:GFPlow-WT |
|
|
|
|
GSE158099 (runx1 -|-) |
whole body |
hematopoietic |
6dpf, cd41:GFPlow-runx1-/- |
|
|
|
|
GSE176129 (pdgfrb-positive) |
whole body |
baseline |
5dpf, FACS-isolated pdgfrb-positive cells |
|
|
|